Cargando…
Spectrum and clinical features of gene mutations in Chinese pediatric acute lymphoblastic leukemia
PURPOSE: The 5-year survival rate of children with acute lymphoblastic leukemia (ALL) is 85–90%, with a 10–15% rate of treatment failure. Next-generation sequencing (NGS) identified recurrent mutated genes in ALL that might alter the diagnosis, classification, prognostic stratification, treatment, a...
Autores principales: | Shen, Diying, Liu, Lixia, Xu, Xiaojun, Song, Hua, Zhang, Jingying, Xu, Weiqun, Zhao, Fenying, Liang, Juan, Liao, Chan, Wang, Yan, Xia, Tian, Wang, Chengcheng, Lou, Feng, Cao, Shanbo, Qin, Jiayue, Tang, Yongmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898934/ https://www.ncbi.nlm.nih.gov/pubmed/36739388 http://dx.doi.org/10.1186/s12887-023-03856-y |
Ejemplares similares
-
Clinical and Genetic Characteristics of IKZF1 Mutation in Chinese Children With B-Cell Acute Lymphoblastic Leukemia
por: Zhang, Jingying, et al.
Publicado: (2022) -
Minimal residual disease detection by next-generation sequencing of different immunoglobulin gene rearrangements in pediatric B-ALL
por: Chen, Haipin, et al.
Publicado: (2023) -
A scoring system based on fusion genes to predict treatment outcomes of the non-acute promyelocytic leukemia pediatric acute myeloid leukemia
por: Weng, Wenwen, et al.
Publicado: (2023) -
Spectrum of Genetic Mutations in Korean Pediatric Acute Lymphoblastic Leukemia
por: Yoo, Jae Won, et al.
Publicado: (2022) -
A Predictor Combining Clinical and Genetic Factors for AML1-ETO Leukemia Patients
por: Yang, Min, et al.
Publicado: (2022)